| 1 | Carcinoma, Ovarian Epithelial | 37.7% |
| 2 | granulosa cell tumor | 33% |
| 3 | Vaginal Neoplasms | 29.1% |
| 4 | Vulvar Neoplasms | 29.1% |
| 5 | Fallopian Tube Neoplasms | 28.9% |
| 6 | Oophoritis | 23.4% |
| 7 | Urologic Neoplasms | 21% |
| 8 | Corpus Luteum Cyst | 20.9% |
| 9 | Ovarian Cysts | 20.9% |
| 10 | Ovarian Hyperstimulation Syndrome | 19.7% |
| 11 | Anovulation | 17.6% |
| 12 | Cystadenocarcinoma | 17.3% |
| 13 | Mucoepidermoid Carcinoma | 17.3% |
| 14 | Endometrial Stromal Sarcoma | 16.9% |
| 15 | Carcinoma, Lobular | 16.9% |
| 16 | Urologic Diseases | 16.2% |
| 17 | Renal Cell Carcinoma | 15.9% |
| 18 | Papillary Renal Cell Carcinoma | 15.9% |
| 19 | Uterine Neoplasms | 15.9% |
| 20 | Uterine Cancer | 15.9% |
| 21 | Choriocarcinoma | 14.8% |
| 22 | Urogenital Abnormalities | 14.5% |
| 23 | Adenoid Cystic Carcinoma | 14.4% |
| 24 | Adenocarcinoma, Clear Cell | 14.4% |
| 25 | Cholangiocarcinoma | 14.4% |
| 26 | Basal cell carcinoma | 14.1% |
| 27 | Carcinoma, Papillary | 14.1% |
| 28 | Squamous cell carcinoma | 14.1% |
| 29 | Carcinoma, Basal Cell | 14.1% |
| 30 | Carcinoid Tumor | 13.8% |
| 31 | Endometriosis | 13.7% |
| 32 | Uterine Diseases | 13.7% |
| 33 | Vaginal Diseases | 13.7% |
| 34 | Vulvar Diseases | 13.7% |
| 35 | Endometrioma | 13.7% |
| 36 | Polycystic Ovary Syndrome | 13.5% |
| 37 | Endometritis | 13.3% |
| 38 | Bladder Neoplasm | 13.2% |
| 39 | Kidney Neoplasm | 13.2% |
| 40 | Ureteral Neoplasms | 13.2% |
| 41 | Urethral Neoplasms | 13.2% |
| 42 | Carcinoma, Ehrlich Tumor | 13.1% |
| 43 | Carcinoma, Lewis Lung | 13.1% |
| 44 | Salpingitis | 13.1% |
| 45 | ovarian neoplasm | 12.4% |
| 46 | Pregnancy Complications, Neoplastic | 12.3% |
| 47 | Infertility | 12.1% |
| 48 | Adrenocortical carcinoma | 11.9% |
| 49 | Hermaphroditism | 11.8% |
| 50 | Disorders of Sex Development | 11.8% |
| 51 | Pregnancy Complications | 11.7% |
| 52 | Carcinoma, Pancreatic Ductal | 11.1% |
| 53 | Neoplasms, Neuroepithelial | 11.1% |
| 54 | Gliomatosis cerebri | 11.1% |
| 55 | Endocrine Gland Neoplasms | 10.9% |
| 56 | Adnexitis | 10.8% |
| 57 | Pelvic Inflammatory Disease | 10.8% |
| 58 | Carcinoma in Situ | 10.8% |
| 59 | Carcinoma, Transitional Cell | 10.8% |
| 60 | Carcinoma, Large Cell | 10.8% |
| 61 | Carcinoma, Small Cell | 10.8% |
| 62 | Nephroblastoma | 10.8% |
| 63 | Klatskin Tumor | 10.7% |
| 64 | Malignant Carcinoid Syndrome | 10.3% |
| 65 | Endometrial Neoplasms | 10.1% |
| 66 | Mesoblastic Nephroma | 10.1% |
| 67 | Premature Menopause | 10.1% |
| 68 | Sexually Transmitted Diseases | 10% |
| 69 | Bladder Exstrophy | 9.8% |
| 70 | Epispadias | 9.8% |
| 71 | Genital Herpes | 9.7% |
| 72 | Tuberculosis, Renal | 9.7% |
| 73 | Uterine Inversion | 9.6% |
| 74 | Multiple Endocrine Neoplasia | 9.5% |
| 75 | Cystadenoma | 9.4% |
| 76 | Mesothelioma | 9.4% |
| 77 | Parathyroid Neoplasms | 9.3% |
| 78 | Thyroid Neoplasm | 9.3% |
| 79 | Thyroid carcinoma | 9.3% |
| 80 | Bowen's Disease | 9.3% |
| 81 | Trophoblastic Neoplasms | 9.2% |
| 82 | Testicular Neoplasms | 9.1% |
| 83 | Adenoma | 9% |
| 84 | Uterine Rupture | 8.6% |
| 85 | Vipoma | 8.6% |
| 86 | Gastrinoma | 8.6% |
| 87 | Glucagonoma | 8.6% |
| 88 | Urinary Bladder Diseases | 8.5% |
| 89 | Kidney Diseases | 8.5% |
| 90 | Ureteral Diseases | 8.5% |
| 91 | Urethral Diseases | 8.5% |
| 92 | Urination Disorders | 8.5% |
| 93 | Urolithiasis | 8.5% |
| 94 | Acanthoma | 8.4% |
| 95 | Multicystic Dysplastic Kidney | 8.4% |
| 96 | Vulvovaginitis | 8.3% |
| 97 | Carcinoma, Endometrioid | 8.3% |
| 98 | leukemia | 8.2% |
| 99 | Neoplasms, Germ Cell and Embryonal | 8.2% |
| 100 | Germ Cell Cancer | 8.2% |
| 101 | Abdominal Neoplasms | 7.9% |
| 102 | Head and Neck Neoplasms | 7.9% |
| 103 | Soft Tissue Neoplasms | 7.9% |
| 104 | Thoracic Neoplasms | 7.9% |
| 105 | Hamartoma | 7.9% |
| 106 | Neoplasms, Hormone-Dependent | 7.9% |
| 107 | Neoplasms, Multiple Primary | 7.9% |
| 108 | Paraneoplastic Syndromes | 7.9% |
| 109 | Precancerous Conditions | 7.9% |
| 110 | Neoplasms, Second Primary | 7.9% |
| 111 | Neuroectodermal Tumors | 7.8% |
| 112 | Carcinoid Heart Disease | 7.8% |
| 113 | Denys-Drash Syndrome | 7.8% |
| 114 | Endometrial Hyperplasia | 7.7% |
| 115 | Pyometra | 7.7% |
| 116 | Vaginitis | 7.7% |
| 117 | Vulvitis | 7.7% |
| 118 | Vaginal Discharge | 7.7% |
| 119 | Vulvodynia | 7.7% |
| 120 | Anuria | 7.7% |
| 121 | Ureterolithiasis | 7.7% |
| 122 | Nephrolithiasis | 7.7% |
| 123 | Urinary tract infection | 7.6% |
| 124 | Horseshoe Kidney | 7.6% |
| 125 | Parametritis | 7.5% |
| 126 | Vesicovaginal Fistula | 7.4% |
| 127 | Basal Cell Nevus Syndrome | 7.3% |
| 128 | Meningioma | 7.3% |
| 129 | Histiocytic Disorders, Malignant | 7.2% |
| 130 | Digestive System Neoplasms | 7.2% |
| 131 | Eye Neoplasms | 7.2% |
| 132 | Nervous System Neoplasms | 7.2% |
| 133 | Cervical Intraepithelial Neoplasia | 7.1% |
| 134 | Pancreatic Neoplasm | 7.1% |
| 135 | Bone neoplasms | 7% |
| 136 | Skin Neoplasms | 7% |
| 137 | Hematologic Neoplasms | 7% |
| 138 | Urinary Bladder Fistula | 7% |
| 139 | Adrenal Gland Neoplasms | 7% |
| 140 | Medulloblastoma | 7% |
| 141 | Splenic Neoplasms | 7% |
| 142 | Cyst | 6.9% |
| 143 | Neoplastic Processes | 6.9% |
| 144 | Neoplastic Syndromes, Hereditary | 6.9% |
| 145 | Hypogonadism | 6.9% |
| 146 | Delayed Puberty | 6.9% |
| 147 | Precocious Puberty | 6.9% |
| 148 | Hypogonadotropic hypogonadism | 6.9% |
| 149 | Testotoxicosis | 6.9% |
| 150 | Neoplasms, Experimental | 6.9% |
| 151 | Hypospadias | 6.8% |
| 152 | Adenoma, Acidophil | 6.8% |
| 153 | Ganglioneuroma | 6.8% |
| 154 | Glioma | 6.8% |
| 155 | Malignant Glioma | 6.8% |
| 156 | Pruritus Vulvae | 6.8% |
| 157 | Uterine hemorrhage | 6.8% |
| 158 | Vaginal Fistula | 6.8% |
| 159 | Uterine Prolapse | 6.8% |
| 160 | Vaginal Prolapse | 6.8% |
| 161 | Gonadal Dysgenesis | 6.7% |
| 162 | Adrenogenital Syndrome | 6.7% |
| 163 | Ovotesticular Disorders of Sex Development | 6.7% |
| 164 | Prolactinoma | 6.7% |
| 165 | Growth Hormone-Secreting Pituitary Adenoma | 6.7% |
| 166 | Leukemia, Experimental | 6.6% |
| 167 | Genital Neoplasms, Male | 6.6% |
| 168 | Paraneoplastic Encephalomyelitis | 6.5% |
| 169 | Carcinoma 256, Walker | 6.5% |
| 170 | Gestational Diabetes | 6.5% |
| 171 | Mammary Neoplasms, Experimental | 6.5% |
| 172 | Lymphoma | 6.4% |
| 173 | Nasopharyngeal carcinoma | 6.4% |
| 174 | Composite Lymphoma | 6.3% |
| 175 | Bladder neck obstruction | 6.2% |
| 176 | Carcinosarcoma | 6.2% |
| 177 | Hemangiosarcoma | 6.2% |
| 178 | lymphangiosarcoma | 6.2% |
| 179 | Neoplasms, Radiation-Induced | 6.2% |
| 180 | Hyperandrogenism | 6.1% |
| 181 | Testicular Diseases | 6.1% |
| 182 | melanoma | 6.1% |
| 183 | Diabetes Insipidus | 6.1% |
| 184 | Dyspareunia | 6.1% |
| 185 | Retinoblastoma | 6.1% |
| 186 | Peritoneal Neoplasms | 6.1% |
| 187 | Kallmann Syndrome | 6% |
| 188 | Leukemia, Radiation-Induced | 6% |
| 189 | Polyhydramnios | 6% |
| 190 | Obstetric Labor Complications | 6% |
| 191 | Ectopic Pregnancy | 6% |
| 192 | Pregnancy, Prolonged | 6% |
| 193 | Puerperal Disorders | 6% |
| 194 | Oligohydramnios | 6% |
| 195 | Prenatal Injuries | 6% |
| 196 | Dermoid Cyst | 5.8% |
| 197 | Chorioamnionitis | 5.8% |
| 198 | Melanoma, Experimental | 5.8% |
| 199 | Tuberous Sclerosis | 5.8% |
| 200 | Uterine Cervical Incompetence | 5.8% |
| 201 | Adenofibroma | 5.8% |
| 202 | Fibroadenoma | 5.8% |
| 203 | Abruptio Placentae | 5.6% |
| 204 | Placenta Accreta | 5.6% |
| 205 | Klinefelter Syndrome | 5.5% |
| 206 | Kidney Calculi | 5.5% |
| 207 | Ureteral Calculi | 5.5% |
| 208 | Leukemia, Plasma Cell | 5.5% |
| 209 | Hepatocellular Adenoma | 5.5% |
| 210 | Fetal Diseases | 5.4% |
| 211 | Pregnancy Complications, Cardiovascular | 5.4% |
| 212 | Diabetic Nephropathy | 5.4% |
| 213 | Thymoma | 5.4% |
| 214 | Papilloma | 5.3% |
| 215 | Pseudomyxoma Peritonei | 5.3% |
| 216 | Papillomatosis | 5.3% |
| 217 | Adenomatosis, Pulmonary | 5.3% |
| 218 | Adenomatous Polyps | 5.3% |
| 219 | Thyroid Nodule | 5.3% |
| 220 | Pregnancy Complications, Hematologic | 5.3% |
| 221 | Pregnancy Complications, Infectious | 5.3% |
| 222 | Fetal Death | 5.3% |
| 223 | Perinatal death | 5.3% |
| 224 | Morning Sickness | 5.2% |
| 225 | Multiple Endocrine Neoplasia Type 1 | 5.2% |
| 226 | Sarcoma, Experimental | 5.2% |
| 227 | Candidiasis, Vulvovaginal | 5.1% |
| 228 | Puerperal Infection | 5% |
| 229 | Postpartum Hemorrhage | 5% |
| 230 | Pituitary Adenoma | 4.8% |
| 231 | Pituitary Neoplasms | 4.8% |
| 232 | Cystitis | 4.8% |
| 233 | Hydronephrosis | 4.8% |
| 234 | Hyperoxaluria | 4.8% |
| 235 | Kidney Cortex Necrosis | 4.8% |
| 236 | Kidney Papillary Necrosis | 4.8% |
| 237 | Nephritis | 4.8% |
| 238 | Nephrosclerosis | 4.8% |
| 239 | Nephrosis | 4.8% |
| 240 | Perinephritis | 4.8% |
| 241 | Kidney Failure | 4.8% |
| 242 | Uremia | 4.8% |
| 243 | Ureteral obstruction | 4.8% |
| 244 | Ureterocele | 4.8% |
| 245 | Urethral Obstruction | 4.8% |
| 246 | Urethritis | 4.8% |
| 247 | Vesico-Ureteral Reflux | 4.8% |
| 248 | Urinary Retention | 4.8% |
| 249 | Oxalosis | 4.8% |
| 250 | Renal Insufficiency | 4.8% |
| 251 | Uterine Cervicitis | 4.8% |
| 252 | Leukorrhea | 4.8% |
| 253 | Tracheal Neoplasms | 4.7% |
| 254 | Astrocytoma | 4.7% |
| 255 | Ependymoma | 4.7% |
| 256 | oligodendroglioma | 4.7% |
| 257 | Ganglioglioma | 4.7% |
| 258 | gliosarcoma | 4.7% |
| 259 | Anaplastic astrocytoma | 4.7% |
| 260 | Anaplastic Oligodendroglioma | 4.7% |
| 261 | Chondrosarcoma | 4.6% |
| 262 | Craniopharyngioma | 4.6% |
| 263 | leiomyosarcoma | 4.6% |
| 264 | liposarcoma | 4.6% |
| 265 | synovial sarcoma | 4.6% |
| 266 | Neuroectodermal Tumor, Melanotic | 4.6% |
| 267 | Angiomyolipoma | 4.6% |
| 268 | Clear Cell Sarcoma of Soft Tissue | 4.6% |
| 269 | Alveolar Soft Part Sarcoma | 4.6% |
| 270 | Neuroendocrine Tumors | 4.6% |
| 271 | Sarcoma, Myeloid | 4.6% |
| 272 | Turner Syndrome | 4.6% |
| 273 | Ameloblastoma | 4.4% |
| 274 | Angiokeratoma | 4.4% |
| 275 | Chordoma | 4.4% |
| 276 | Hemangioma | 4.4% |
| 277 | hemangiopericytoma | 4.4% |
| 278 | Lymphangioma | 4.4% |
| 279 | Mesenchymoma | 4.4% |
| 280 | Nevus | 4.4% |
| 281 | Teratoma | 4.4% |
| 282 | Hepatoblastoma | 4.4% |
| 283 | Mixed Tumor, Mullerian | 4.4% |
| 284 | Germinoma | 4.4% |
| 285 | Teratocarcinoma | 4.4% |
| 286 | Angiofibroma | 4.4% |
| 287 | Sarcoma | 4.4% |
| 288 | Leydig Cell Tumor | 4.3% |
| 289 | insulinoma | 4.3% |
| 290 | Hepatorenal Syndrome | 4.3% |
| 291 | Bacteriuria | 4.3% |
| 292 | Glycosuria | 4.3% |
| 293 | Hematuria | 4.3% |
| 294 | Renal hypertension | 4.3% |
| 295 | Oliguria | 4.3% |
| 296 | Polyuria | 4.3% |
| 297 | Proteinuria | 4.3% |
| 298 | Pyuria | 4.3% |
| 299 | Renal Artery Obstruction | 4.3% |
| 300 | Renal Artery Stenosis | 4.3% |
| 301 | Urinary Calculi | 4.3% |
| 302 | Cystocele | 4.3% |
| 303 | Nephrocalcinosis | 4.3% |
| 304 | Urinary Incontinence | 4.3% |
| 305 | Esophageal Neoplasms | 4.3% |
| 306 | Bacterial Vaginosis | 4.2% |
| 307 | Adrenal Gland Diseases | 4.2% |
| 308 | Parathyroid Diseases | 4.2% |
| 309 | Thyroid Diseases | 4.2% |
| 310 | Retroperitoneal Neoplasms | 4.2% |
| 311 | Leukemia L1210 | 4.2% |
| 312 | Leukemia P388 | 4.2% |
| 313 | Trichomonas Vaginitis | 4.2% |
| 314 | Uterine Perforation | 4.2% |
| 315 | Metrorrhagia | 4.2% |
| 316 | Liver Neoplasms, Experimental | 4.1% |
| 317 | Pyelocystitis | 4% |
| 318 | Erythroplasia | 4% |
| 319 | Follicular cyst | 4% |
| 320 | Mucocele | 4% |
| 321 | Pilonidal Cyst | 4% |
| 322 | Thyroglossal Cyst | 4% |
| 323 | Synovial Cyst | 4% |
| 324 | Aberrant Crypt Foci | 4% |
| 325 | Adenomatous Polyposis Coli | 4% |
| 326 | Lymphomatoid Granulomatosis | 4% |
| 327 | Neurilemmoma | 4% |
| 328 | Hutchinson's Melanotic Freckle | 4% |
| 329 | Melanoma, Amelanotic | 4% |
| 330 | Plasmacytoma | 3.9% |
| 331 | Malignant histiocytosis | 3.9% |
| 332 | Histiocytic sarcoma | 3.9% |
| 333 | Enuresis | 3.9% |
| 334 | Fibrosarcoma | 3.8% |
| 335 | Osteosarcoma | 3.8% |
| 336 | Mouth Neoplasms | 3.7% |
| 337 | Central Nervous System Neoplasms | 3.7% |
| 338 | Vascular Neoplasms | 3.7% |
| 339 | Thymus Neoplasms | 3.7% |
| 340 | Optic Nerve Glioma | 3.7% |
| 341 | Bone Diseases, Endocrine | 3.7% |
| 342 | Menorrhagia | 3.7% |
| 343 | Genital Neoplasms, Female | 3.7% |
| 344 | Diabetes Mellitus | 3.7% |
| 345 | Breast Neoplasms, Male | 3.7% |
| 346 | Triple Negative Breast Neoplasms | 3.7% |
| 347 | Pituitary Diseases | 3.7% |
| 348 | Glycosuria, Renal | 3.7% |
| 349 | Lymphangioleiomyomatosis | 3.7% |
| 350 | Orchitis | 3.6% |
| 351 | Glioblastoma | 3.6% |
| 352 | Neuroblastoma | 3.6% |
| 353 | Glioblastoma Multiforme | 3.6% |
| 354 | Acoustic Neuroma | 3.6% |
| 355 | Leukoplakia | 3.6% |
| 356 | Lymphocele | 3.6% |
| 357 | Pancreatic Cyst | 3.6% |
| 358 | Barrett Esophagus | 3.5% |
| 359 | Breast Cyst | 3.5% |
| 360 | Actinic keratosis | 3.5% |
| 361 | Mediastinal Cyst | 3.5% |
| 362 | Neoplasm Invasiveness | 3.5% |
| 363 | Neoplasm Metastasis | 3.5% |
| 364 | Neoplasm Recurrence, Local | 3.5% |
| 365 | Parovarian Cyst | 3.5% |
| 366 | Pericardial Cyst | 3.5% |
| 367 | Thymic Cyst | 3.5% |
| 368 | Carcinogenesis | 3.5% |
| 369 | Myxoid cyst | 3.5% |
| 370 | Metastasis | 3.5% |
| 371 | AIDS-Associated Nephropathy | 3.5% |
| 372 | Hodgkin Disease | 3.5% |
| 373 | Lymphoma, Non-Hodgkin | 3.5% |
| 374 | Renal Osteodystrophy | 3.4% |
| 375 | Renal rickets | 3.4% |
| 376 | Sarcoma 180 | 3.4% |
| 377 | Malignant Fibrous Histiocytoma | 3.4% |
| 378 | Gastrointestinal Neoplasms | 3.4% |
| 379 | Liver neoplasms | 3.4% |
| 380 | Uveal Neoplasms | 3.4% |
| 381 | Pyelonephritis | 3.3% |
| 382 | Ovarian Diseases | 3.3% |
| 383 | Dwarfism | 3.3% |
| 384 | Sebaceous Gland Neoplasms | 3.3% |
| 385 | Spinal Neoplasms | 3.3% |
| 386 | Bone Marrow Neoplasms | 3.3% |
| 387 | Penile Neoplasms | 3.3% |
| 388 | Prostatic Neoplasms | 3.3% |
| 389 | Leukoplakia, Oral | 3.2% |
| 390 | Paraneoplastic Cerebellar Degeneration | 3.2% |
| 391 | Abortion, Habitual | 3.2% |
| 392 | Dystocia | 3.2% |
| 393 | Eclampsia | 3.2% |
| 394 | Fetal Membranes, Premature Rupture | 3.2% |
| 395 | Placental Insufficiency | 3.2% |
| 396 | Pre-Eclampsia | 3.2% |
| 397 | Prenatal Exposure Delayed Effects | 3.2% |
| 398 | HELLP Syndrome | 3.2% |
| 399 | Placenta, Retained | 3.2% |
| 400 | Hydatidiform Mole | 3.2% |
| 401 | Primary amyloidosis | 3.1% |
| 402 | Ganglioneuroblastoma | 3.1% |
| 403 | Chlamydia Infections | 3.1% |
| 404 | Gonorrhea | 3.1% |
| 405 | Glomerulonephritis | 3% |
| 406 | Nephritis, Interstitial | 3% |
| 407 | Lipoid nephrosis | 3% |
| 408 | Nephrotic Syndrome | 3% |
| 409 | Pyelitis | 3% |
| 410 | Pyonephrosis | 3% |
| 411 | Urethral Stenosis | 3% |
| 412 | Nephrogenic Diabetes Insipidus | 3% |
| 413 | Congenital Nephrogenic Diabetes Insipidus | 3% |
| 414 | Acute kidney injury | 3% |
| 415 | Urethral stricture | 3% |
| 416 | Paraganglioma | 3% |
| 417 | Rhabdomyosarcoma | 3% |
| 418 | Giant Cell Tumor of Bone | 3% |
| 419 | Neurofibrosarcoma | 3% |
| 420 | Cryptorchidism | 2.9% |
| 421 | Limbic Encephalitis | 2.9% |
| 422 | Abortion, Veterinary | 2.9% |
| 423 | Pregnancy Complications, Parasitic | 2.9% |
| 424 | Choledochal Cyst | 2.9% |
| 425 | Peutz-Jeghers Syndrome | 2.8% |
| 426 | Lactation Disorder | 2.8% |
| 427 | Mastitis | 2.8% |
| 428 | Depression, Postpartum | 2.8% |
| 429 | Embryo Loss | 2.8% |
| 430 | Syphilis | 2.8% |
| 431 | Fetal Resorption | 2.8% |
| 432 | Hyperemesis Gravidarum | 2.8% |
| 433 | Lambert-Eaton Myasthenic Syndrome | 2.7% |
| 434 | Azotemia | 2.7% |
| 435 | Nose Neoplasms | 2.7% |
| 436 | Albuminuria | 2.7% |
| 437 | Hemoglobinuria | 2.7% |
| 438 | Hypertension, Renovascular | 2.7% |
| 439 | Urge Incontinence | 2.6% |
| 440 | Waldenstrom Macroglobulinemia | 2.6% |
| 441 | Multiple Myeloma | 2.6% |
| 442 | Phyllodes Tumor | 2.6% |
| 443 | Dysgerminoma | 2.6% |
| 444 | Hemangioendothelioma | 2.6% |
| 445 | Lipoma | 2.6% |
| 446 | Myoma | 2.6% |
| 447 | Myxoma | 2.6% |
| 448 | Neuroma | 2.6% |
| 449 | Seminoma | 2.6% |
| 450 | Angiolipoma | 2.6% |
| 451 | Myelolipoma | 2.6% |
| 452 | Neoplasms, Bone Tissue | 2.6% |
| 453 | Neoplasms, Fibrous Tissue | 2.6% |
| 454 | Smooth Muscle Tumor | 2.6% |
| 455 | Desmoplastic Small Round Cell Tumor | 2.6% |
| 456 | Chondroma | 2.6% |
| 457 | Enchondroma | 2.6% |
| 458 | Dermatofibrosarcoma | 2.6% |
| 459 | Dermatofibrosarcoma Protuberans | 2.6% |
| 460 | Fetal Growth Retardation | 2.5% |
| 461 | Embolism, Amniotic Fluid | 2.5% |
| 462 | Fetal Hypoxia | 2.5% |
| 463 | Fetal Alcohol Spectrum Disorders | 2.5% |
| 464 | Opsoclonus-Myoclonus Syndrome | 2.5% |
| 465 | Breech Presentation | 2.5% |
| 466 | Stillbirth | 2.5% |
| 467 | Zellweger Syndrome | 2.4% |
| 468 | Polycystic Kidney Diseases | 2.4% |
| 469 | Diurnal Enuresis | 2.4% |
| 470 | Renal Aminoacidurias | 2.4% |
| 471 | Fanconi Syndrome | 2.4% |
| 472 | Pseudohypoaldosteronism | 2.4% |
| 473 | Liddle Syndrome | 2.4% |
| 474 | Hemolytic-Uremic Syndrome | 2.4% |
| 475 | Congenital Hypothyroidism | 2.4% |
| 476 | Myelitis, Transverse | 2.3% |
| 477 | Nelson Syndrome | 2.3% |
| 478 | Adrenal Cortex Diseases | 2.3% |
| 479 | Euthyroid Sick Syndromes | 2.3% |
| 480 | Goiter | 2.3% |
| 481 | Hyperparathyroidism | 2.3% |
| 482 | Hyperthyroidism | 2.3% |
| 483 | Hyperthyroxinemia | 2.3% |
| 484 | Hypoparathyroidism | 2.3% |
| 485 | Hypothyroidism | 2.3% |
| 486 | Thyroiditis | 2.3% |
| 487 | Secondary hypothyroidism | 2.3% |
| 488 | Primary Hyperthyroidism | 2.3% |
| 489 | Primary Hypothyroidism | 2.3% |
| 490 | Leukemia, Myelomonocytic, Chronic | 2.3% |
| 491 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2.3% |
| 492 | Palatal Neoplasms | 2.3% |
| 493 | Pheochromocytoma | 2.2% |
| 494 | Alveolar rhabdomyosarcoma | 2.2% |
| 495 | Renal tubular acidosis | 2.2% |
| 496 | Meconium Aspiration Syndrome | 2.1% |
| 497 | Meningeal Neoplasms | 2.1% |
| 498 | Lymphogranuloma Venereum | 2.1% |
| 499 | Balkan Nephropathy | 2.1% |
| 500 | Focal glomerulosclerosis | 2.1% |
| 501 | Kidney Failure, Chronic | 2.1% |
| 502 | Mastocytosis | 2.1% |
| 503 | Sturge-Weber Syndrome | 2.1% |
| 504 | Gastrointestinal Stromal Tumors | 2.1% |
| 505 | Xeroderma Pigmentosum | 2% |
| 506 | Hemangioma, Cavernous | 2% |
| 507 | Leukemia, T-Cell | 2% |
| 508 | Leukemia, B-Cell | 2% |
| 509 | neurofibroma | 2% |
| 510 | Lymphoma, Follicular | 2% |
| 511 | T-Cell Lymphoma | 2% |
| 512 | Mantle cell lymphoma | 2% |
| 513 | Empty Sella Syndrome | 2% |
| 514 | Hyperpituitarism | 2% |
| 515 | Hypopituitarism | 2% |
| 516 | Hypophysitis | 2% |
| 517 | Prostatic Neoplasms, Castration-Resistant | 2% |
| 518 | Neoplasms, Glandular and Epithelial | 2% |
| 519 | Graves Disease | 2% |
| 520 | Pancreatic Pseudocyst | 1.9% |
| 521 | Ear Neoplasms | 1.9% |
| 522 | Eyelid Neoplasms | 1.9% |
| 523 | Lung Neoplasms | 1.9% |
| 524 | Pleural Neoplasms | 1.9% |
| 525 | Glomerulonephritis, Membranoproliferative | 1.9% |
| 526 | Lymphatic Metastasis | 1.9% |
| 527 | Neoplasms, Unknown Primary | 1.9% |
| 528 | Leukemic Infiltration | 1.9% |
| 529 | Neoplasm Micrometastasis | 1.9% |
| 530 | Brain Neoplasms | 1.9% |
| 531 | Salivary Gland Neoplasms | 1.9% |
| 532 | Spinal Cord Neoplasms | 1.9% |
| 533 | Tongue Neoplasms | 1.9% |
| 534 | Hyperphosphaturia | 1.8% |
| 535 | Premature Birth | 1.8% |
| 536 | Latent Autoimmune Diabetes in Adults | 1.8% |
| 537 | Diabetes Mellitus, Experimental | 1.8% |
| 538 | Pharyngeal Neoplasms | 1.7% |
| 539 | Central Nervous System Cysts | 1.7% |
| 540 | fibroma | 1.7% |
| 541 | Fibromatosis | 1.7% |
| 542 | Osteoblastoma | 1.7% |
| 543 | Osteoma | 1.7% |
| 544 | Rhabdomyoma | 1.7% |
| 545 | Chondromatosis | 1.7% |
| 546 | Hemangioblastoma | 1.7% |
| 547 | Lymphoma, Extranodal NK-T-Cell | 1.7% |
| 548 | Bile Duct Neoplasms | 1.7% |
| 549 | gallbladder neoplasm | 1.7% |
| 550 | Intestinal Neoplasms | 1.7% |
| 551 | Stomach Neoplasms | 1.7% |
| 552 | Anti-Glomerular Basement Membrane Disease | 1.7% |
| 553 | Lupus Nephritis | 1.7% |
| 554 | Polycythemia Vera | 1.7% |
| 555 | Polycystic Kidney, Autosomal Dominant | 1.7% |
| 556 | Cystinuria | 1.7% |
| 557 | Atypical Hemolytic Uremic Syndrome | 1.7% |
| 558 | Pituitary Apoplexy | 1.6% |
| 559 | Galactorrhea | 1.6% |
| 560 | Laryngeal neoplasm | 1.6% |
| 561 | Mastocytoma | 1.5% |
| 562 | Mastocytosis, Systemic | 1.5% |
| 563 | Leukemia, Myeloid, Chronic-Phase | 1.5% |
| 564 | Cushing Syndrome | 1.4% |
| 565 | Hyperaldosteronism | 1.4% |
| 566 | Hyperparathyroidism, Secondary | 1.4% |
| 567 | Hypoaldosteronism | 1.4% |
| 568 | Thyrotoxicosis | 1.4% |
| 569 | Hyperparathyroidism, Primary | 1.4% |
| 570 | Thyroid Hormone Resistance Syndrome | 1.4% |
| 571 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.3% |
| 572 | Leukemia, Large Granular Lymphocytic | 1.3% |
| 573 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1.3% |
| 574 | Lymphoma, T-Cell, Cutaneous | 1.3% |
| 575 | Lymphoma, AIDS-Related | 1.3% |
| 576 | Enteropathy-Associated T-Cell Lymphoma | 1.3% |
| 577 | Primary Effusion Lymphoma | 1.3% |
| 578 | Meningeal Carcinomatosis | 1.3% |
| 579 | Diabetic Foot | 1.3% |
| 580 | Fibromatosis, Aggressive | 1.2% |
| 581 | Fibromatosis, Abdominal | 1.2% |
| 582 | Addison Disease | 1.2% |
| 583 | Diabetic Angiopathies | 1.2% |
| 584 | Autoimmune thyroiditis | 1.2% |
| 585 | Primary Adrenal Insufficiency | 1.2% |
| 586 | Diabetic Neuropathies | 1.2% |
| 587 | Myxedema | 1.2% |
| 588 | Diabetic Amyotrophy | 1.2% |
| 589 | Diabetic Autonomic Neuropathy | 1.2% |
| 590 | Diabetic Cardiomyopathies | 1.2% |
| 591 | Hyperprolactinemia | 1.2% |
| 592 | Zollinger-Ellison syndrome | 1.2% |
| 593 | Bronchial Neoplasms | 1.2% |
| 594 | Multiple Pulmonary Nodules | 1.2% |
| 595 | Supratentorial Neoplasms | 1.1% |
| 596 | Burkitt Lymphoma | 1.1% |
| 597 | Gigantism | 1.1% |
| 598 | Acromegaly | 1.1% |
| 599 | Diabetic Ketoacidosis | 1.1% |
| 600 | Hypopharyngeal Neoplasms | 1% |
| 601 | Pleural Effusion, Malignant | 1% |
| 602 | Hypopharyngeal Cancer | 1% |
| 603 | Parotid Neoplasms | 1% |
| 604 | Carcinoma | 1% |
| 605 | Epithelioma | 1% |
| 606 | Hydrops Fetalis | 1% |
| 607 | Dupuytren Contracture | 1% |
| 608 | Cell Transformation, Viral | 1% |
| 609 | Urticaria Pigmentosa | 1% |
| 610 | Mycosis Fungoides | 1% |
| 611 | Lymphomatoid Papulosis | 1% |
| 612 | Plasmablastic lymphoma | 1% |
| 613 | Cecal Neoplasms | 0.9% |
| 614 | Duodenal Neoplasms | 0.9% |
| 615 | Familial Hypophosphatemic Rickets | 0.9% |
| 616 | Hyperglycemic Hyperosmolar Nonketotic Coma | 0.9% |
| 617 | Hashimoto Disease | 0.9% |
| 618 | Nasopharyngeal Neoplasms | 0.9% |
| 619 | Colorectal Neoplasms | 0.9% |
| 620 | Paranasal Sinus Neoplasms | 0.8% |
| 621 | Sezary Syndrome | 0.8% |
| 622 | Brain Stem Neoplasms | 0.8% |
| 623 | Diabetic Retinopathy | 0.7% |
| 624 | Tonsillar Neoplasms | 0.7% |
| 625 | Cerebellar Neoplasms | 0.7% |
| 626 | Appendiceal Neoplasms | 0.6% |
| 627 | Colonic Neoplasms | 0.6% |
| 628 | Rectal Neoplasms | 0.6% |
| 629 | Waterhouse-Friderichsen Syndrome | 0.6% |
| 630 | Choroid Plexus Papilloma | 0.6% |
| 631 | Adenocarcinoma | 0.6% |
| 632 | Maxillary Sinus Neoplasms | 0.6% |
| 633 | Anus Neoplasms | 0.5% |
| 634 | Sigmoid Neoplasms | 0.5% |
| 635 | Adrenoleukodystrophy | 0.4% |
| 636 | Radicular Cyst | 0.4% |
